Bobak Azamian is a Newport Beach-based Investment Professional and specializes in medical device investing and company building at Versant Ventures.
Bobby joined Versant from Third Rock Ventures, where he led the medical device team, resulting in investment in several companies. He also actively provided support and guidance for these companies in early operational roles and as a board observer. Previously, Bobby was a scientific consultant at Amgen. He also practices medicine as a hospitalist at Kaiser Permanente, and was formerly at Brigham and Women’s Hospital and on the faculty of Harvard Medical School.
Currently, Bobby serves as founder, President and CEO, and board member of Metavention, an early-stage Versant portfolio company. He is also a board observer at Inceptus Medical, Intersection Medical, MD Start, and Sequent Medical. Additionally, he is a board member of OCTANe and serves on the Leadership Council of the The Edwards Lifesciences Center for Advanced Cardiovascular Technology at UC Irvine.
Bobby holds an MD from the Harvard-MIT Division of Health Sciences and Technology; a DPhil in Chemistry from Oxford University as a Rhodes Scholar; and a BA in Physics from Rice University.